| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Cardioprotection: A New Paradigm in the Management of Acute Heart Failure Syndromes
|
Maytin, Melanie
|
|
2005
|
96 |
6S |
p. 26-31
6 p.
|
article
|
| 2 |
CME
|
|
|
2005
|
96 |
6S |
p. 91-99
9 p.
|
article
|
| 3 |
Definition and Epidemiology of Acute Heart Failure Syndromes
|
Nieminen, Markku S.
|
|
2005
|
96 |
6S |
p. 5-10
6 p.
|
article
|
| 4 |
European Experience on the Practical Use of Levosimendan in Patients with Acute Heart Failure Syndromes
|
Follath, Ferenc
|
|
2005
|
96 |
6S |
p. 80-85
6 p.
|
article
|
| 5 |
Evaluation and Monitoring of Patients with Acute Heart Failure Syndromes
|
Nohria, Anju
|
|
2005
|
96 |
6S |
p. 32-40
9 p.
|
article
|
| 6 |
Introduction to Acute Heart Failure Syndromes
|
Gheorghiade, Mihai
|
|
2005
|
96 |
6S |
p. 1-4
4 p.
|
article
|
| 7 |
Overview of Current Noninodilator Therapies for Acute Heart Failure Syndromes
|
Gattis Stough, Wendy
|
|
2005
|
96 |
6S |
p. 41-46
6 p.
|
article
|
| 8 |
Overview of Randomized Clinical Trials in Acute Heart Failure Syndromes
|
Teerlink, John R.
|
|
2005
|
96 |
6S |
p. 59-67
9 p.
|
article
|
| 9 |
Pathophysiologic Targets in the Early Phase of Acute Heart Failure Syndromes
|
Gheorghiade, Mihai
|
|
2005
|
96 |
6S |
p. 11-17
7 p.
|
article
|
| 10 |
Pharmacology of New Agents for Acute Heart Failure Syndromes
|
Gheorghiade, Mihai
|
|
2005
|
96 |
6S |
p. 68-73
6 p.
|
article
|
| 11 |
Randomized Clinical Trials with Levosimendan
|
Mebazaa, Alexandre
|
|
2005
|
96 |
6S |
p. 74-79
6 p.
|
article
|
| 12 |
Reassessment of Dobutamine, Dopamine, and Milrinone in the Management of Acute Heart Failure Syndromes
|
Bayram, Melike
|
|
2005
|
96 |
6S |
p. 47-58
12 p.
|
article
|
| 13 |
The Challenge of Acute Heart Failure Syndromes
|
Gheorghiade, Mihai
|
|
2005
|
96 |
6S |
p. 86-89
4 p.
|
article
|
| 14 |
The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVD-HF)
|
Gheorghiade, Mihai
|
|
2005
|
96 |
6S |
p. 18-25
8 p.
|
article
|
Journal description